APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Structure

Global Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026192 pages

Choose your research edition.

Industry ResearchNuclear Medicine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.

Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.

Read the full market overview

The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.

Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.

Report Includes

This report provides an overview of the global Nuclear Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nuclear Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Medicine Segment by Company

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Triad Isotopes

Nordion

Jubilant Pharma

Eli Lilly

SIEMENS

China Isotope & Radiation

Dongcheng

Nuclear Medicine Segment by Type

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Others

Nuclear Medicine Segment by Application

Diagnostic

Therapeutic

Nuclear Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nuclear Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine industry.

Chapter 3: Detailed analysis of Nuclear Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tc-99 Table 3. Key Players of I-123/131 Table 4. Key Players of In-111 Table 3. Key Players of Xe-133 Table 4. Key Players of Th-201 Table 5. Key Players of Ga-67 Table 6. Key Players of Others Table 7. Global Nuclear Medicine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Diagnostic Table 9. Key Players of Therapeutic Table 10. Global Nuclear Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Nuclear Medicine Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Nuclear Medicine Market Share by Region (2021-2026) Table 13. Global Nuclear Medicine Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Nuclear Medicine Market Share by Region (2027-2032) Table 15. Nuclear Medicine Industry Trends Table 16. Nuclear Medicine Industry Drivers Table 17. Nuclear Medicine Industry Opportunities and Challenges Table 18. Nuclear Medicine Industry Restraints Table 19. Global Nuclear Medicine Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Nuclear Medicine Revenue Market Share by Company (2021-2026) Table 21. Global Nuclear Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Nuclear Medicine Key Company Head Office and Area Served Table 23. Global Nuclear Medicine Company, Product Type & Application Table 24. Global Nuclear Medicine Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Nuclear Medicine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Nuclear Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Nuclear Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Nuclear Medicine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Nuclear Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Nuclear Medicine Revenue Market Share by Application (2027-2032) Table 37. GE Healthcare Company Information Table 38. GE Healthcare Business Overview Table 39. GE Healthcare Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. GE Healthcare Nuclear Medicine Product Portfolio Table 41. GE Healthcare Recent Development Table 42. Bracco Imaging Company Information Table 43. Bracco Imaging Business Overview Table 44. Bracco Imaging Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bracco Imaging Nuclear Medicine Product Portfolio Table 46. Bracco Imaging Recent Development Table 47. Mallinckrodt Company Information Table 48. Mallinckrodt Business Overview Table 49. Mallinckrodt Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Mallinckrodt Nuclear Medicine Product Portfolio Table 51. Mallinckrodt Recent Development Table 52. Lantheus Medical Imaging Company Information Table 53. Lantheus Medical Imaging Business Overview Table 54. Lantheus Medical Imaging Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Lantheus Medical Imaging Nuclear Medicine Product Portfolio Table 56. Lantheus Medical Imaging Recent Development Table 57. Bayer Company Information Table 58. Bayer Business Overview Table 59. Bayer Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bayer Nuclear Medicine Product Portfolio Table 61. Bayer Recent Development Table 62. Triad Isotopes Company Information Table 63. Triad Isotopes Business Overview Table 64. Triad Isotopes Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Triad Isotopes Nuclear Medicine Product Portfolio Table 66. Triad Isotopes Recent Development Table 67. Nordion Company Information Table 68. Nordion Business Overview Table 69. Nordion Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Nordion Nuclear Medicine Product Portfolio Table 71. Nordion Recent Development Table 72. Jubilant Pharma Company Information Table 73. Jubilant Pharma Business Overview Table 74. Jubilant Pharma Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Jubilant Pharma Nuclear Medicine Product Portfolio Table 76. Jubilant Pharma Recent Development Table 77. Eli Lilly Company Information Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Eli Lilly Nuclear Medicine Product Portfolio Table 81. Eli Lilly Recent Development Table 82. SIEMENS Company Information Table 83. SIEMENS Business Overview Table 84. SIEMENS Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. SIEMENS Nuclear Medicine Product Portfolio Table 86. SIEMENS Recent Development Table 87. China Isotope & Radiation Company Information Table 88. China Isotope & Radiation Business Overview Table 89. China Isotope & Radiation Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. China Isotope & Radiation Nuclear Medicine Product Portfolio Table 91. China Isotope & Radiation Recent Development Table 92. Dongcheng Company Information Table 93. Dongcheng Business Overview Table 94. Dongcheng Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Dongcheng Nuclear Medicine Product Portfolio Table 96. Dongcheng Recent Development Table 97. North America Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Nuclear Medicine Market Size by Country (2021-2026) Table 103. North America Nuclear Medicine Market Size by Country (2027-2032) Table 104. Europe Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Nuclear Medicine Market Size by Country (2021-2026) Table 110. Europe Nuclear Medicine Market Size by Country (2027-2032) Table 111. China Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 112. China Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 113. China Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 114. China Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Nuclear Medicine Market Size by Country (2021-2026) Table 121. Asia Nuclear Medicine Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Nuclear Medicine Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Nuclear Medicine Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Nuclear Medicine Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Nuclear Medicine Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Nuclear Medicine Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Nuclear Medicine Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Nuclear Medicine Product Image Figure 2. Global Nuclear Medicine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nuclear Medicine Market Share by Type: 2025 VS 2032 Figure 4. Tc-99 Image Figure 5. I-123/131 Image Figure 6. In-111 Image Figure 7. Xe-133 Image Figure 8. Th-201 Image Figure 9. Ga-67 Image Figure 10. Others Image Figure 11. Global Nuclear Medicine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Nuclear Medicine Market Share by Application: 2025 VS 2032 Figure 13. Diagnostic Image Figure 14. Therapeutic Image Figure 15. Global Nuclear Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 17. Global Nuclear Medicine Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Nuclear Medicine Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Nuclear Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nuclear Medicine Revenue Market Share by Type (2021-2032) Figure 24. Global Nuclear Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Nuclear Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 27. North America Nuclear Medicine Market Share by Type (2021-2032) Figure 28. North America Nuclear Medicine Market Share by Application (2021-2032) Figure 29. North America Nuclear Medicine Market Share by Country (2021-2032) Figure 30. United States Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 31. Canada Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 34. Europe Nuclear Medicine Market Share by Type (2021-2032) Figure 35. Europe Nuclear Medicine Market Share by Application (2021-2032) Figure 36. Europe Nuclear Medicine Market Share by Country (2021-2032) Figure 37. Germany Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 38. France Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 40. Italy Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 41. Russia Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 43. China Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 44. China Nuclear Medicine Market Share by Type (2021-2032) Figure 45. China Nuclear Medicine Market Share by Application (2021-2032) Figure 46. Asia Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 47. Asia Nuclear Medicine Market Share by Type (2021-2032) Figure 48. Asia Nuclear Medicine Market Share by Application (2021-2032) Figure 49. Asia Nuclear Medicine Market Share by Country (2021-2032) Figure 50. Japan Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 54. India Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 55. Australia Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Nuclear Medicine Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Nuclear Medicine Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Nuclear Medicine Market Share by Country (2021-2032) Figure 60. Brazil Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 65. UAE Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 67. Chile Nuclear Medicine Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99
  • I-123/131
  • In-111
  • Xe-133
  • Th-201
  • Ga-67
  • Others
Applications
  • Diagnostic
  • Therapeutic
Companies covered
  • GE Healthcare
  • Bracco Imaging
  • Mallinckrodt
  • Lantheus Medical Imaging
  • Bayer
  • Triad Isotopes
  • Nordion
  • Jubilant Pharma
  • Eli Lilly
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99
  5. 1.2.3 I-123/131
  6. 1.2.4 In-111
  7. 1.2.5 Xe-133
  8. 1.2.6 Th-201
  9. 1.2.7 Ga-67
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Nuclear Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Diagnostic
  14. 1.3.3 Therapeutic
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Nuclear Medicine Growth Trends by Region
  17. 1.5.1 Global Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Nuclear Medicine Market Size by Region (2021-2026)
  19. 1.5.3 Nuclear Medicine Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Nuclear Medicine Market Dynamics
  1. 2.1 Nuclear Medicine Industry Trends
  2. 2.2 Nuclear Medicine Industry Drivers
  3. 2.3 Nuclear Medicine Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nuclear Medicine Revenue by Company (2021-2026)
  2. 3.2 Global Nuclear Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nuclear Medicine Key Company Head office and Area Served
  4. 3.4 Global Nuclear Medicine Company, Product Type & Application
  5. 3.5 Global Nuclear Medicine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nuclear Medicine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nuclear Medicine Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine Market by Type
  1. 4.1 Global Nuclear Medicine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nuclear Medicine Market Size by Type (2021-2032)
  3. 4.3 Global Nuclear Medicine Market Size Share by Type (2021-2032)
5 Nuclear Medicine Market by Application
  1. 5.1 Global Nuclear Medicine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nuclear Medicine Market Size by Application (2021-2032)
  3. 5.3 Global Nuclear Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GE Healthcare
  2. 6.1.1 GE Healthcare Company Information
  3. 6.1.2 GE Healthcare Business Overview
  4. 6.1.3 GE Healthcare Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GE Healthcare Nuclear Medicine Product Portfolio
  6. 6.1.5 GE Healthcare Recent Developments
  7. 6.2 Bracco Imaging
  8. 6.2.1 Bracco Imaging Company Information
  9. 6.2.2 Bracco Imaging Business Overview
  10. 6.2.3 Bracco Imaging Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
  12. 6.2.5 Bracco Imaging Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Lantheus Medical Imaging
  20. 6.4.1 Lantheus Medical Imaging Company Information
  21. 6.4.2 Lantheus Medical Imaging Business Overview
  22. 6.4.3 Lantheus Medical Imaging Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
  24. 6.4.5 Lantheus Medical Imaging Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bayer Nuclear Medicine Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Triad Isotopes
  32. 6.6.1 Triad Isotopes Company Information
  33. 6.6.2 Triad Isotopes Business Overview
  34. 6.6.3 Triad Isotopes Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
  36. 6.6.5 Triad Isotopes Recent Developments
  37. 6.7 Nordion
  38. 6.7.1 Nordion Company Information
  39. 6.7.2 Nordion Business Overview
  40. 6.7.3 Nordion Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nordion Nuclear Medicine Product Portfolio
  42. 6.7.5 Nordion Recent Developments
  43. 6.8 Jubilant Pharma
  44. 6.8.1 Jubilant Pharma Company Information
  45. 6.8.2 Jubilant Pharma Business Overview
  46. 6.8.3 Jubilant Pharma Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
  48. 6.8.5 Jubilant Pharma Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Eli Lilly Nuclear Medicine Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 SIEMENS
  56. 6.10.1 SIEMENS Company Information
  57. 6.10.2 SIEMENS Business Overview
  58. 6.10.3 SIEMENS Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 SIEMENS Nuclear Medicine Product Portfolio
  60. 6.10.5 SIEMENS Recent Developments
  61. 6.11 China Isotope & Radiation
  62. 6.11.1 China Isotope & Radiation Company Information
  63. 6.11.2 China Isotope & Radiation Business Overview
  64. 6.11.3 China Isotope & Radiation Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
  66. 6.11.5 China Isotope & Radiation Recent Developments
  67. 6.12 Dongcheng
  68. 6.12.1 Dongcheng Company Information
  69. 6.12.2 Dongcheng Business Overview
  70. 6.12.3 Dongcheng Nuclear Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Dongcheng Nuclear Medicine Product Portfolio
  72. 6.12.5 Dongcheng Recent Developments
7 North America
  1. 7.1 North America Nuclear Medicine Market Size (2021-2032)
  2. 7.2 North America Nuclear Medicine Market Size by Type
  3. 7.2.1 North America Nuclear Medicine Market Size by Type (2021-2026)
  4. 7.2.2 North America Nuclear Medicine Market Size by Type (2027-2032)
  5. 7.2.3 North America Nuclear Medicine Market Share by Type (2021-2032)
  6. 7.3 North America Nuclear Medicine Market Size by Application
  7. 7.3.1 North America Nuclear Medicine Market Size by Application (2021-2026)
  8. 7.3.2 North America Nuclear Medicine Market Size by Application (2027-2032)
  9. 7.3.3 North America Nuclear Medicine Market Share by Application (2021-2032)
  10. 7.4 North America Nuclear Medicine Market Size by Country
  11. 7.4.1 North America Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nuclear Medicine Market Size by Country (2021-2026)
  13. 7.4.3 North America Nuclear Medicine Market Size by Country (2027-2032)
  14. 7.4.4 North America Nuclear Medicine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nuclear Medicine Market Size (2021-2032)
  2. 8.2 Europe Nuclear Medicine Market Size by Type
  3. 8.2.1 Europe Nuclear Medicine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nuclear Medicine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nuclear Medicine Market Share by Type (2021-2032)
  6. 8.3 Europe Nuclear Medicine Market Size by Application
  7. 8.3.1 Europe Nuclear Medicine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nuclear Medicine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nuclear Medicine Market Share by Application (2021-2032)
  10. 8.4 Europe Nuclear Medicine Market Size by Country
  11. 8.4.1 Europe Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nuclear Medicine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nuclear Medicine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nuclear Medicine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nuclear Medicine Market Size (2021-2032)
  2. 9.2 China Nuclear Medicine Market Size by Type
  3. 9.2.1 China Nuclear Medicine Market Size by Type (2021-2026)
  4. 9.2.2 China Nuclear Medicine Market Size by Type (2027-2032)
  5. 9.2.3 China Nuclear Medicine Market Share by Type (2021-2032)
  6. 9.3 China Nuclear Medicine Market Size by Application
  7. 9.3.1 China Nuclear Medicine Market Size by Application (2021-2026)
  8. 9.3.2 China Nuclear Medicine Market Size by Application (2027-2032)
  9. 9.3.3 China Nuclear Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nuclear Medicine Market Size (2021-2032)
  2. 10.2 Asia Nuclear Medicine Market Size by Type
  3. 10.2.1 Asia Nuclear Medicine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nuclear Medicine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nuclear Medicine Market Share by Type (2021-2032)
  6. 10.3 Asia Nuclear Medicine Market Size by Application
  7. 10.3.1 Asia Nuclear Medicine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nuclear Medicine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nuclear Medicine Market Share by Application (2021-2032)
  10. 10.4 Asia Nuclear Medicine Market Size by Country
  11. 10.4.1 Asia Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nuclear Medicine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nuclear Medicine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nuclear Medicine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nuclear Medicine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nuclear Medicine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nuclear Medicine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nuclear Medicine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nuclear Medicine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nuclear Medicine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nuclear Medicine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nuclear Medicine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nuclear Medicine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nuclear Medicine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nuclear Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nuclear Medicine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nuclear Medicine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nuclear Medicine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst